PRESS RELEASE published on 03/16/2026 at 18:00, 4 months 23 days ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC converteert 4 obligaties in Oxurion, resulterend in EUR 100.000 kapitaalverhoging. Oxurion verhoogt totaal aantal gewone aandelen naar 88.691.312 Kapitaalverhoging Atlas Special Opportunities Aandelen Oxurion Converteerbare Obligaties
PRESS RELEASE published on 03/16/2026 at 18:00, 4 months 23 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 4 bonds in Oxurion, resulting in EUR 100,000 capital increase. Oxurion issues 18.59M new shares as part of a EUR 20M Capital Commitment agreement with Atlas Convertible Bonds Capital Increase Share Issuance Atlas Special Opportunities Oxurion
BRIEF published on 03/10/2026 at 18:35, 4 months 29 days ago Oxurion étend son programme de financement avec Atlas Special Opportunities Obligations Convertibles Capitalisation Boursière Financement D'Oxurion Accord Atlas Échéance De L'obligation
BRIEF published on 03/10/2026 at 18:35, 4 months 29 days ago Oxurion Extends Financing Program with Atlas Special Opportunities Convertible Bonds Market Capitalization Oxurion Financing Atlas Agreement Bond Maturity
BRIEF published on 03/10/2026 at 18:35, 4 months 29 days ago Oxurion prolonge son programme de financement jusqu'à 2027 Financement Obligations Convertibles Capitalisation Boursière Oxurion Prolongation
BRIEF published on 03/10/2026 at 18:35, 4 months 29 days ago Oxurion extends its financing program until 2027 Convertible Bonds Funding Extension Market Capitalization Oxurion
PRESS RELEASE published on 03/10/2026 at 18:30, 4 months 29 days ago Oxurion verlengt haar financieringsprogramma Oxurion NV, ein belgisches Biofarmazieunternehmen, verlängert und modifiziert das Finanzierungsprogramm mit Atlas Special Opportunities II, LLC Finanzierung Oxurion Belgien Atlas Special Opportunities II, LLC Biofarmazie
PRESS RELEASE published on 03/10/2026 at 18:30, 4 months 29 days ago Oxurion prolonge son programme de financement Oxurion NV prolonge son programme de financement d'obligations convertibles avec Atlas Special Opportunities II, LLC jusqu'au 2 mars 2027 et ajuste les conditions de financement Financement Obligations Convertibles Avenant Oxurion NV Atlas Special Opportunities II LLC
PRESS RELEASE published on 03/10/2026 at 18:30, 4 months 29 days ago Oxurion Extends Its Financing Program Oxurion NV extends financing program with Atlas Special Opportunities II, LLC. Amendments include 12-month extension, adjusted maturity terms, and right to transfer bonds internationally Biopharmaceutical Company Oxurion NV Financing Program Atlas Special Opportunities II LLC Bond Subscription Agreement
BRIEF published on 02/27/2026 at 18:05, 5 months 9 days ago Oxurion continues discussions for the acquisition of a French CRO Acquisition Pharmaceutical Due Diligence Oxurion French CRO
Published on 08/07/2026 at 23:15, 20 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 20 hours 15 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 20 hours 45 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 21 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 2 hours 49 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 19 hours 54 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 23 hours 45 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day 1 hour ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 1 day ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 1 hour ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026